Request for Approval Non-substantial Change

EIP 0920-0978_Non-sub change request_Oct2022FOR2023.docx

[NCEZID] Emerging Infections Program

Request for Approval Non-substantial Change

OMB: 0920-0978

Document [docx]
Download: docx | pdf


Emerging Infections Programs (EIP)

OMB Control Number 0920-0978

Expiration Date: 02/28/2026

Non-Substantive Change Request






















Submission Date: 02/08/2023










Program Contact


Sonja Mali Nti-Berko

Emerging Infections Programs (EIP)

Division of Preparedness and Emerging Infections

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

1600 Clifton Rd, MS-C18

Atlanta, GA 30329

Phone: (404) 488-4780

E-mail: [email protected]




Table of Contents and Attachments




  1. Non-Substantive Change Request Justification Document

  2. Description of Changes (Attachment #1)

  3. Cross-Walk 2022 to 2023 (Attachment #2)

  4. ABCs: ABCs Case Report Form (Attachment #3)

  5. ABCs: ABCs Neonatal Infection Expanded Tracking Form (Attachment #4)

  6. FoodNet: FoodNet Active Surveillance Data Elements List (Attachment #5)

  7. FoodNet: FoodNet Hemolytic Uremic Syndrome (Attachment #6)

  8. FoodNet: Diagnostic Laboratory Practices and Volume Data Elements List (Attachment #7)

  9. FluSurv-NET: Influenza Hospitalization Surveillance Network Case Report Form (Attachment #8)

  10. FluSurv-NET: FluSurv-NET/RSV-NET Hospital Laboratory Survey (Attachment #9)

  11. FluSurv-NET: COVID-19 Vaccination Status on FluSurv-NET Cases (Attachment #10)

  12. HAIC: Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form (Attachment #11)

  13. HAIC: Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form (Attachment #12)

  14. HAIC: Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales / Invasive Escherichia coli (iEC) Multi-site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form (CRF) (Attachment #13)

  15. HAIC: Carbapenem-Resistant Enterobacterales (CRE) and Carbapenem-Resistant Acinetobacter baumannii (CRAB) Multi-site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form (CRF) (Attachment #14)

  16. HAIC: CDI Case Report and Treatment Form (Attachment #15)

  17. HAIC: CDI Annual Surveillance Officers Survey (Attachment #16)

  18. HAIC: Annual Survey of Laboratory Testing Practices for C. difficile Infections (Attachment #17)

  19. HAIC: Candidemia Case Report (Attachment #18)

  20. HAIC: Laboratory Testing Practices for Candidemia Questionnaire (Attachment #19)

  21. HAIC: Invasive Staphylococcus aureus Supplemental Surveillance Officer (Attachment #20)

  22. HAIC: Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT) (Attachment #21)




Justification for Change Request for OMB 0920-0978


This is a nonmaterial/non-substantive change request for OMB No. 0920-0978, expiration date 02/26/2026, for the Emerging Infections Programs (EIP). All requested changes represent minor modifications to already-approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions.


The Emerging Infections Programs (EIPs) are population-based centers of excellence established through a network of state health departments collaborating with academic institutions, local health departments, public health and clinical laboratories, infection control professionals, and healthcare providers. EIPs assist in local, state, and national efforts to prevent, control, and monitor the public health impact of infectious diseases.


Activities of the EIPs fall into the following general categories: (1) active surveillance; (2) applied public health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention/intervention projects; and (4) flexible response to public health emergencies. Activities of the EIPs are designed to: (1) address issues that the EIP network is particularly suited to investigate; (2) maintain sufficient flexibility for emergency response and new problems as they arise; (3) develop and evaluate public health interventions to inform public health policy and treatment guidelines; (4) incorporate training as a key function; and (5) prioritize projects that lead directly to the prevention of disease.


Activities in the EIP Network in which all applicants must participate are:

  • Active Bacterial Core surveillance (ABCs): active population-based laboratory surveillance for invasive bacterial diseases.

  • Foodborne Diseases Active Surveillance Network (FoodNet): active population-based laboratory surveillance to monitor the incidence of select enteric diseases.

  • Influenza Hospitalization Surveillance Network (FluSurv-NET): active population-based surveillance for laboratory confirmed influenza-related hospitalizations.

  • Healthcare-Associated Infections-Community Interface (HAIC) surveillance: active population-based surveillance for healthcare-associated pathogens and infections.


This non-substantive change request is for changes to the disease-specific data elements for ABCs, FoodNet, FluSurv-NET, and HAIC. The changes made to all forms under this non-substantive request will aid in improving surveillance efficiency and data quality to clarify the burden of disease and possible risk factors for disease. This information can be used to inform strategies for preventing disease and negative outcomes. Specifically, changes were made for clarification purposes, to assist data collectors in capturing data in a standardized fashion to improve accuracy. As a result of proposed changes, the estimated annualized burden is expected to increase by 392 hours, from 55,394 to 55,786. The data elements and justifications are described below.


The forms for which approval for changes are being sought include:



ABCs:

  1. 2023 ABCs Case Report Form

  2. 2023 ABCs Neonatal Infection Expanded Tracking Form


Food Net:

  1. FoodNet Active Surveillance Data Elements List

  2. FoodNet Hemolytic Uremic Syndrome

  3. Diagnostic Laboratory Practices and Volume Data Elements List


FluSurv-NET:

  1. FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form

  2. FluSurv-NET/RSV-NET Laboratory Survey

  3. COVID-19 Vaccination Status on FluSurv-NET Cases (optional form)

  4. Patient/Proxy Influenza Vaccination Phone Script and Consent Form (Pediatric/Adult) in Spanish (Form deleted)


HAIC:

  1. 2020 Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form

  2. 2020 Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form

  3. Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales / Invasive Escherichia coli (iEC) Multi-site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form (CRF)

  4. Carbapenem-Resistant Enterobacterales (CRE) and Carbapenem-Resistant Acinetobacter baumannii (CRAB) Multi-site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form (CRF)

  5. CDI Case Report and Treatment Form

  6. CDI Annual Surveillance Officers Survey

  7. Annual Survey of Laboratory Testing Practices for C. difficile Infections

  8. Candidemia Case Report

  9. Laboratory Testing Practices for Candidemia Questionnaire

  10. Invasive Staphylococcus aureus Supplemental Surveillance Officer

  11. Invasive Staphylococcus aureus Laboratory Survey: Use of Nucleic Acid Amplification Testing (NAAT)





Estimated Annualized Burden Hours

As a result of proposed changes to forms highlighted in yellow, the estimated annualized burden is expected to increase by 392 hours, from 55,394 to 55,786. The figures highlighted in red are the forms where there was a change in burden hours.



The following table is updated for the entire 0920-0978 burden table. The forms included in this change request are highlighted:


Table A.12-A1. Estimated Annualized Burden Hours


Type of Respondent

Form Name

No. of respondents

No. of responses per respondent

Avg. burden per response (in hours)

Current Total burden (in hours)

Proposed

Total burden (in hours)

State Health Department


ABCs Case Report Form

10

809

20/60

2697

2697

ABCs Invasive Pneumococcal Disease in Children and Adults Case Report Form

10

127

10/60

212

212

ABCs H. influenzae Neonatal Sepsis Expanded Surveillance Form

10

6

10/60

10

10

ABCs Severe GAS Infection Supplemental Form

10

136

20/60

453

453

ABCs Neonatal Infection Expanded Tracking Form

10

37

20/60

123

123

FoodNet Campylobacter

10

970

21/60

3395

3395

FoodNet Cyclospora

10

42

10/60

70

70

FoodNet Listeria monocytogenes

10

16

20/60

53

53

FoodNet Salmonella

10

855

21/60

2993

2993

FoodNet Shiga toxin producing E. coli

10

290

20/60

967

967

FoodNet Shigella

10

234

10/60

390

390

FoodNet Vibrio

10

46

10/60

77

77

FoodNet Yersinia

10

55

10/60

92

92

FoodNet Hemolytic Uremic Syndrome

10

10

1

100

100

FoodNet Clinical Laboratory Practices and Testing Volume

10

70

10/60

233

117

FluSurv-Net

Influenza Hospitalization Surveillance Network Case Report Form

14

776

25/60

3183

4526



FluSurv-Net

Influenza Hospitalization Surveillance Project Vaccination Phone Script and Consent Form (English/Spanish)

14

22

10/60

278

51

FluSurv-Net

Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults)

14

70

5/60

278

82

FluSurv-NET Laboratory Survey

14

16

10/60

26

37

COVID Vaccination Status on FluSurv-NET cases (optional) – (new form)

7

776

0


0

HAIC - MuGSI Case Report Form for Carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii (CRAB)

10

500

28/60

2333

2333

HAIC - MuGSI Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae (ESBL/iEC)

10

4200

25/60

19,600

19,600

HAIC - Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form

10

322


28/60


1605

1503

HAIC - Invasive Methicillin-sensitive Staphylococcus aureus (MSSA) Infection Case Report Form

10

466


28/60


2217

2175

HAIC - CDI Case Report and Treatment Form

10

1650

38/60

10450

10450

HAIC Candidemia Case Report

10

170

40/60

1134

1134

HAIC- Annual Survey of Laboratory Testing Practices for C. difficile Infections

10

16

17/60

51

46

HAIC- CDI Annual Surveillance Officers Survey

10

1

15/60

3

3

HAIC- Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey (LTCF)

10

45

5/60

38

38

HAIC- Invasive Staphylococcus aureus Laboratory Survey

10

11

20/60

37

37

HAIC- Invasive Staphylococcus aureus Supplemental Surveillance Officers Survey

10

1

10/60


2


2

HAIC- Laboratory Testing Practices for Candidemia Questionnaire

10

20

14/60

43

47

HAIC MuGSI CA CP-CRE Health interview

10

10

30/60

50

50

HAIC MuGSI Supplemental Surveillance Officer Survey

10

1

15/60

3

3

HAIC Death Ascertainment Project

10

8

1440/60

1,920

1,920

TOTAL


55,394

55,786



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleOMB CY 08
Authorwsb2
File Modified0000-00-00
File Created2024-07-27

© 2024 OMB.report | Privacy Policy